GeneTex
United States (US)

Galectin 7 recombinant protein

Galectin-7-recombinant-protein-GTX65163-WB-1_18121410_684.jpg

Cat No. GTX65163

Application WB, ELISA, Functional Assay, Apuri, Blocking
Reactivity Human
Species Human
APPLICATION

Application Note

Measured by its ability to agglutinate human red blood cells. The ED50 for the effect is typically 1-7 ug/ml.

Calculated MW

15.4 kDa. ( Note )
PROPERTIES

Form

Lyophilized powder

Storage

Reconstitute in water to a concentration of 0.1-1.0 mg/ml. This solution can then be diluted into other aqueous buffers. Store at -20ºC.

Antigen Species

Human

Expression System

E. coli

Purification


Purity was assessed by SDS-PAGE (≥98%) and by HPLC (≥98%).

Note

For laboratory use only. Not for any clinical, therapeutic, or diagnostic use in humans or animals. Not for animal or human consumption.
TARGET

Synonyms

Gal7, Galactein7, PI7, HKL-14, HKL14, p53induced gene 1 protein, Gal-7, p53-induced gene 1 protein, p53induced gene1 protein, LGALS7, Galectin7, Galactein 7, Gal 7, HKL 14, p53 induced gene 1 protein

Background

Galectin-7 belongs to growing family of evolutionary conserved animal lectins. Galectins consists of beta-galactoside binding lectins that contain homologous carbohydrate recognition domains (CRDs). Galectin has the ability to induce apoptosis of activated T-cells and T-leukaemia cell lines. Other activities include cell differentiation and inhibition activity of CD45 protein phosphatase activity. Galectin also binds beta-galactoside as well as CD45, CD3 and CD4. Recombinant Human Galectin-7 is a 15.4 kDa protein consisting of 136 amino acid residues

Research Area

DATA IMAGES
Galectin-7-recombinant-protein-GTX65163-WB-1_18121410_684.jpg

GTX65163 WB Image

Purity of recombinant human Galectin-7 (2 µg) was analyzed by SDS-PAGE electrophoresis.

Package List Price ($)
$ 199